Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg QD Versus Placebo In Patients With OA Of The Knee

NCT00650624 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00650624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00650624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg QD Versus Placebo In Patients With OA Of The Knee
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
January 31, 2004
Enrollment
416 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee